For: | Chen YH, Li CL, Chen WJ, Liu J, Wu HT. Diverse roles of FOXO family members in gastric cancer. World J Gastrointest Oncol 2021; 13(10): 1367-1382 [PMID: 34721771 DOI: 10.4251/wjgo.v13.i10.1367] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v13/i10/1367.htm |
Number | Citing Articles |
1 |
Yihan Yang, Xu Shu, Chuan Xie. An Overview of Autophagy in Helicobacter pylori Infection and Related Gastric Cancer. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.847716
|
2 |
Tengyang Ni, Zewen Chu, Li Tao, Yang Zhao, Miao Zhu, Yuanyuan Luo, Masataka Sunagawa, Haibo Wang, Yanqing Liu. PTBP1 drives c-Myc-dependent gastric cancer progression and stemness. British Journal of Cancer 2023; 128(6): 1005 doi: 10.1038/s41416-022-02118-5
|
3 |
Suryaa Manoharan, Kunjkumar Prajapati, Ekambaram Perumal. Natural bioactive compounds and FOXO3a in cancer therapeutics: An update. Fitoterapia 2024; 173: 105807 doi: 10.1016/j.fitote.2023.105807
|
4 |
Shuhong Tian, Keyan Zhong, Zhaoxin Yang, Jian Fu, Yangbo Cai, Min Xiao. Investigating the mechanism of tricyclic decyl benzoxazole -induced apoptosis in liver Cancer cells through p300-mediated FOXO3 activation. Cellular Signalling 2024; 121: 111280 doi: 10.1016/j.cellsig.2024.111280
|
5 |
Zheng Zhang, Nanfang Huang, Feng Xv, Sida Zhao, Juan Guo, Youshan Zhao, Chunkang Chang. Decreased FOXO1 Expression Is Correlated with Poor Prognosis in Myelodysplastic Syndromes. Current Oncology 2022; 29(10): 6933 doi: 10.3390/curroncol29100545
|
6 |
Parisa Zeynali, Hossein Teimouri, Seyed Mohammad Ali Hashemi, Arefeh Ebrahimian, Seyed Nooreddin Faraji, Shahriar Sakhaei, Emad Behboudi. Epstein-Barr Virus and <i>Helicobacter pylori</i> as Two Main Risk Factors in Gastric Cancer. OBM Genetics 2024; 8(04): 1 doi: 10.21926/obm.genet.2404272
|
7 |
Wenxin Feng, Chunxiao Ma, Hanyu Rao, Wei Zhang, Changwei Liu, Yue Xu, Rebiguli Aji, Ziyi Wang, Jin Xu, Wei-Qiang Gao, Li Li. Setd2 deficiency promotes gastric tumorigenesis through inhibiting the SIRT1/FOXO pathway. Cancer Letters 2023; 579: 216470 doi: 10.1016/j.canlet.2023.216470
|
8 |
Farzaneh Motamedi, Mehri Khatami, Mohammad Mehdi Heidari, Mansoureh Azadeh, Negar Karami. Evaluation of the expression of LINCOO475 and FOXO1 genes as tumor suppressor genes in breast cancer: Correlation of bioinformatics tools and experimental approaches. Gene Reports 2024; 36: 101980 doi: 10.1016/j.genrep.2024.101980
|
9 |
Ying Liu, Xiang Ao, Yi Jia, Xiaoge Li, Yu Wang, Jianxun Wang. The FOXO family of transcription factors: key molecular players in gastric cancer. Journal of Molecular Medicine 2022; 100(7): 997 doi: 10.1007/s00109-022-02219-x
|
10 |
Kun Chen, Peng Gao, Zongchao Li, Aonan Dai, Ming Yang, Siyu Chen, Jingyue Su, Zhenhan Deng, Liangjun Li. Forkhead Box O Signaling Pathway in Skeletal Muscle Atrophy. The American Journal of Pathology 2022; 192(12): 1648 doi: 10.1016/j.ajpath.2022.09.003
|
11 |
Yating Zhu, Chenguang Zhang, Qiuyu Yin, Wenting Xu, Yulou Luo, Jianghua Ou. FOXO4 suppresses cisplatin resistance of triple-negative breast cancer by inhibiting autophagy. The American Journal of the Medical Sciences 2024; doi: 10.1016/j.amjms.2024.08.012
|
12 |
Fu Peng, Minru Liao, Rui Qin, Shiou Zhu, Cheng Peng, Leilei Fu, Yi Chen, Bo Han. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01110-y
|
13 |
Gouranga Saha, Srija Roy, Malini Basu, Mrinal K. Ghosh. USP7 - a crucial regulator of cancer hallmarks. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(3): 188903 doi: 10.1016/j.bbcan.2023.188903
|
14 |
Geng Geng, Qinghao Li, Xingqing Guo, Qingbin Ni, Yongtao Xu, Zhaolong Ma, Yongjin Wang, Ming Ming. FOXO3a‑modulated DEPDC1 promotes malignant progression of nephroblastoma via the Wnt/β‑catenin signaling pathway. Molecular Medicine Reports 2022; 26(2) doi: 10.3892/mmr.2022.12788
|
15 |
Bruno F. Santos, Inês Grenho, Paulo J. Martel, Bibiana I. Ferreira, Wolfgang Link. FOXO family isoforms. Cell Death & Disease 2023; 14(10) doi: 10.1038/s41419-023-06177-1
|
16 |
Muhammad Yasir, Jinyoung Park, Wanjoo Chun. EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma. International Journal of Molecular Sciences 2023; 24(20): 15173 doi: 10.3390/ijms242015173
|
17 |
Zhenya Tan, Ke Pan, Minqiong Sun, Xianzhu Pan, Zhi Yang, Zhiling Chang, Xue Yang, Jicheng Zhu, Li Zhan, Yakun Liu, Xiaofei Li, Keqiong Lin, Lin Chen, Hui Mo, Wei Luo, Chen Kan, Lunxi Duan, Hong Zheng. CCKBR+ cancer cells contribute to the intratumor heterogeneity of gastric cancer and confer sensitivity to FOXO inhibition. Cell Death & Differentiation 2024; 31(10): 1302 doi: 10.1038/s41418-024-01360-z
|
18 |
Wen Zhang, Dan Liu, Jian Yi, Jianmin Fan. Downregulation of circAsxl2 Relieves Neuronal Injury Induced by oxygen-glucose deprivation/reperfusion. Molecular Neurobiology 2024; 61(2): 812 doi: 10.1007/s12035-023-03532-3
|
19 |
Xavier T. R. Moore, Lilia Gheghiani, Zheng Fu. The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors. Cells 2023; 12(9): 1344 doi: 10.3390/cells12091344
|
20 |
Changfeng Xiao, Xueyao Wu, C. Scott Gallagher, Danielle Rasooly, Xia Jiang, Cynthia Casson Morton. Genetic contribution of reproductive traits to risk of uterine leiomyomata: a large-scale, genome-wide, cross-trait analysis. American Journal of Obstetrics and Gynecology 2024; 230(4): 438.e1 doi: 10.1016/j.ajog.2023.12.040
|
21 |
Xionghui Rao, Chaojun Zhang, Huixing Luo, Jianbao Zhang, Zhehong Zhuang, Zhihao Liang, Xiaobin Wu. Targeting Gastric Cancer Stem Cells to Enhance Treatment Response. Cells 2022; 11(18): 2828 doi: 10.3390/cells11182828
|